The impact of sodium glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonists on insulin utilisation and costs in Australia: a national retrospective observational cross-sectional study
The Lancet Regional Health - Western Pacific, Journal Year: 2024, Volume and Issue: 52, P. 101207 - 101207
Published: Sept. 24, 2024
Language: Английский